Skip to main content

Table 4 The overall survival difference between higher and lower methylation groups in LUAD

From: Genomic and immunogenomic analysis of three prognostic signature genes in LUAD

Symbol

Tag

sur_type

P_value

HR

Group

HOXC8

cg19634247

OS

0.161562

1.247549

Higher meth

HOXC8

cg19634247

PFS

0.026401

1.341563

Higher meth

HOXC8

cg19634247

DSS

0.142748

1.341601

Higher meth

HOXC8

cg19634247

DFI

0.020919

1.700252

Higher meth

MMP12

cg20487452

OS

0.079336

0.755476

Lower meth

MMP12

cg20487452

PFS

0.004617

0.685559

Lower meth

MMP12

cg20487452

DSS

0.042944

0.662403

Lower meth

MMP12

cg20487452

DFI

0.019631

0.583485

Lower meth

NFE2

cg24762231

OS

0.538537

1.101948

Higher meth

NFE2

cg24762231

PFS

0.827304

0.971628

Lower meth

NFE2

cg24762231

DSS

0.743642

0.936438

Lower meth

NFE2

cg24762231

DFI

0.491236

0.854394

Lower meth

  1. OS overall survival, PFS progression free survival, DSS disease specific survival, and DFI disease free interval, meth. Methylation